Kevin M. Brennan insider trades
Open-market stock purchases and sales by Kevin M. Brennan, SVP, FINANCE AND ACCOUNTING at Xilio Therapeutics, Inc, from SEC Form 4 filings since Apr 1, 2023.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Jan 2, 2026 | XLO Xilio Therapeutics, Inc | Sold | $1.2K |
| Jan 1, 2026 | XLO Xilio Therapeutics, Inc | Bought (not open market) | — |
| Dec 31, 2025 | XLO Xilio Therapeutics, Inc | Bought (not open market) | — |
| Nov 21, 2025 | XLO Xilio Therapeutics, Inc | Sold (not open market) | $21.6K |
| Nov 21, 2025 | XLO Xilio Therapeutics, Inc | Bought (not open market) | $20K |
| Nov 21, 2025 | XLO Xilio Therapeutics, Inc | Bought (not open market) | — |
| Nov 21, 2025 | XLO Xilio Therapeutics, Inc | Sold (not open market) | $174K |
| Nov 21, 2025 | XLO Xilio Therapeutics, Inc | Bought (not open market) | $55K |
| Nov 21, 2025 | XLO Xilio Therapeutics, Inc | Sold (not open market) | $69.6K |
| Nov 21, 2025 | XLO Xilio Therapeutics, Inc | Bought (not open market) | $25K |
Companies traded
- XLO Xilio Therapeutics, Inc: 2 sales, last Jan 2, 2026